Related Experiment Video
Updated: Feb 11, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
HER2-targeted molecular probes for cancer imaging: construction, optimization, and clinical applications
Xinyu Guo1,2, Wenjiao Min3, Zhengyu Li1,2
1Department of Gynecology and Obstetrics, West China Second University Hospital, Sichuan University, Chengdu, China.
Abstract:
The expression of human epidermal growth factor receptor 2 (HER2) is a critical biomarker for guiding precision therapy in HER2-positive cancers. However, conventional diagnostic approaches are invasive and fail to resolve the spatiotemporal heterogeneity of HER2 expression. Molecular imaging using HER2-targeted probes provides a noninvasive alternative, enabling quantitative assessment of HER2 status at the whole-body level. This capability supports critical clinical needs including early molecular subtyping, sensitive detection of metastases, and dynamic monitoring of treatment response. This review focuses on the rational design and engineering strategies of emerging HER2-targeted probes, highlighting key advances in probe architecture and functional optimization. We systematically evaluate how optimization strategies improve imaging contrast, metabolic stability, and targeting specificity. Despite considerable preclinical progress, the widespread clinical translation of these probes remains challenged by issues in scalable manufacturing, reproducible quality control, and regulatory validation. Addressing these application barriers represents a critical objective for future research to fully realize the potential of HER2-targeted molecular imaging in precision oncology.
Insights
Molecular imaging probes offer a noninvasive way to assess human epidermal growth factor receptor 2 (HER2) in cancers. Optimizing these probes can improve imaging and patient care, but clinical translation requires addressing manufacturing and regulatory hurdles.
Area of Science:
- Oncology
- Molecular Imaging
- Biomarker Development
Background:
- Human epidermal growth factor receptor 2 (HER2) expression is crucial for precision cancer therapy.
- Current HER2 diagnostics are invasive and cannot capture HER2 expression heterogeneity.
- Molecular imaging offers noninvasive, quantitative HER2 assessment for improved clinical management.
Purpose of the Study:
- To review the design and engineering of novel HER2-targeted molecular imaging probes.
- To evaluate strategies for optimizing probe performance, including contrast, stability, and specificity.
- To identify challenges hindering the clinical translation of HER2-targeted imaging probes.
Main Methods:
- Systematic review of HER2-targeted probe design and optimization strategies.
- Evaluation of probe architecture and functional modifications.
- Analysis of preclinical advancements and clinical translation barriers.
Main Results:
- HER2-targeted probes enable noninvasive, whole-body assessment of HER2 status.
- Probe optimization enhances imaging contrast, metabolic stability, and targeting specificity.
- Significant preclinical progress has been made in developing advanced HER2 probes.
Conclusions:
- HER2-targeted molecular imaging supports early subtyping, metastasis detection, and treatment monitoring.
- Overcoming manufacturing, quality control, and regulatory challenges is essential for clinical adoption.
- Further research is needed to fully leverage HER2-targeted imaging in precision oncology.
More Related Videos
Related Concept Videos
Applications of Molecular Taxonomy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Clinical Applications of Epidermal Stem Cells
Local Anesthetics: Clinical Application as Spinal Anesthesia
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Molecular Orbital Theory I

